CancerDrugs – Delhi Tightens Oversight to Prevent Misuse of Empty Oncology Medicine Vials
CancerDrugs –The Delhi government has strengthened monitoring of cancer medicines by directing hospitals to maintain detailed records and ensure the immediate destruction of empty drug containers after use, aiming to stop counterfeit medicines from entering the healthcare system.
The Delhi government has issued fresh instructions to hospitals providing oncology services, requiring them to follow stricter procedures for handling cancer medicines. The move comes amid concerns that empty vials of expensive cancer drugs are being illegally collected, refilled with fake or low-quality substances, and circulated as genuine medicines. Officials said the new measures are intended to protect patients and strengthen the integrity of the pharmaceutical supply chain.
Advisory Focuses on Safe Handling of Cancer Drug Containers
The Drugs Control Department recently circulated an advisory to hospitals with oncology departments, asking them to maintain comprehensive records of cancer medicines and ensure that empty vials and ampules are destroyed immediately after use. According to the department, these precautions are necessary to prevent discarded containers from being reused by criminal networks involved in manufacturing counterfeit medicines.
The advisory notes that costly cancer therapies, particularly advanced immunotherapy drugs, have increasingly become targets for illegal activities because of their high market value. Authorities warned that reused containers filled with fake or substandard products could pose serious health risks to patients who depend on these medicines for life-saving treatment.
Hospitals Asked to Strengthen Procurement Practices
The government has instructed hospitals to purchase oncology medicines only from licensed and authorised suppliers. Medical institutions have also been directed to preserve complete procurement records, including invoices, supplier information and batch numbers, so that every medicine can be traced if any issue arises.
Officials believe that maintaining accurate documentation will improve accountability and make it easier to investigate suspected cases involving counterfeit or diverted medicines. The advisory encourages healthcare providers to remain vigilant throughout the procurement process to reduce opportunities for fraudulent products to enter hospital inventories.
Immediate Destruction of Empty Vials Made Mandatory
Under the latest guidelines, hospitals must ensure that every empty vial or ampule becomes unusable immediately after administering the medicine. This can be achieved by crushing the container or permanently damaging its label before disposal, while following the applicable biomedical waste management rules.
Authorities have made it clear that intact empty containers should never be discarded or transferred without first being destroyed. Hospitals have also been advised to establish internal monitoring systems to prevent used containers from being removed, stolen or diverted before disposal.
Additional Verification Measures Introduced
To improve patient safety, hospitals have been encouraged to verify the authenticity of cancer medicines using available manufacturer authentication systems, barcode verification tools and other approved methods. These verification steps are expected to help identify suspicious products before they reach patients.
The advisory also recommends maintaining a detailed record of every vial received and administered, creating a complete audit trail for high-value cancer medicines. Officials believe such documentation will enhance transparency and assist regulatory agencies in detecting irregularities more quickly.
Government Aims to Protect Patients and Drug Supply Chain
The latest directive reflects growing concern over the increasing sophistication of counterfeit medicine operations. By combining stricter procurement standards, improved record-keeping and mandatory destruction of empty drug containers, the Delhi government aims to reduce opportunities for fake medicines to re-enter the market.
Officials said the measures are designed to reinforce patient safety while ensuring that genuine cancer medicines remain protected throughout the supply chain. Hospitals have been urged to implement the advisory without delay and regularly review their internal procedures to ensure full compliance.